CII-PwC report: 77% Indian households use ayurvedic products

Increased emphasis on lifestyle and wellness, driven by a rise in non-communicable and chronic diseases, is driving the demand for ayurveda in India, according to a report by Confederation of Indian Industry (CII) and Pricewaterhouse-Coopers (PwC). The report said 77% of Indian households used ayurvedic products in 2017, up from 69% in 2015. The global market for ayurveda is estimated to almost treble from $3.4-bn in 2015 to $9.7-bn by 2022.
The report calls for a paradigm shift in core ayurvedic industries using technology as an enabler, to meet the increasing demand. It emphasises the need for standardisation and quality control to launch ayurveda on a global scale.
Key role for Kerala
Kerala is well positioned to cater to this rising demand for ayurvedic products and services. The state is singularly advantaged in its ability to deliver ayurvedic products and services, in all segments of ayurveda, the report said.
Kerala, known as the cradle of ayurveda, has many advantages when it comes to ayurveda. The state’s core capabilities are strengthened by a range of products and services, advancements in research and education, increase in tourism and strong support from the government. Thanks to these advantages, Kerala is well on the way to becoming a hub for investment in ayurveda, and companies making and marketing ayurvedic medicines, the report added.
Kerala had 1,400 ayurveda-associated industries with a total turnover of $37-mn and export of $8.3-mn in 2016. It accounts for 10% of the Indian herbal industry of $578-mn.
2026-08-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Cold Cycle: PVC Market’s Chill and Faint Light Ahead
-
Echoes of Overcapacity: The Structural Anxiety of China’s EVA Industry Chain
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Clean Food Group Secures UK, EU, and US Approval for Fermentation-Derived Cosmetic Oils
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Egypt’s Chemical Surge: $9.4 Billion Export Boom Signals Industrial Powerhouse Rise
-
NOVA Chemicals Launches PE Resins with Next-Generation Non-Fluoropolymer Processing Aid
-
UAE Withdraws from OPEC
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
Recommend Reading
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Middle East Conflict Hits the Electronics Supply Chain as PPE Resin Shortage Sends PCB Prices Up 40%
-
CP Chem Doubles PAO Capacity in Belgium to 120000 Tons Now Europe’s Largest Low-Viscosity Base Oil Facility
-
China Unveils Battery Breakthrough with 600Wh/kg Cell Flight Endurance Boosted 2.8 Times
-
Premium Global Chemical Sourcing Requests (8-12 Dec 2025)
-
Uses and Properties of 3-Methyl-1-Butanol
-
Key Reactions and Uses of Lithium Aluminum Hydride
-
Inventory Accumulation Expectations Remain, PTA Prices Continue to Fluctuate and Weaken
-
September Hydrogen Peroxide Market Warms Up